People

• Year of birth: 1979
• Hometown: Seoul, Hàn Quốc
• Nationality: South Korea
• Qualification: MBA University of Chicago Booth School of Business

Employment History

• March 2003- August 2010: Analyst, Corporate Banking at Standard Chartered Bank
• August 2012 - March 2016: Associate, Investment Banking at J.P. Morgan
• April 2016 to present: Head of Vietnam - SK SUPEX Council, South Korea

• Year of birth: 1952
• Hometown: Dong Thap
• Nationality: Vietnamese
• Qualification: Bachelor of Pharmacy

A 30-year career has led to her current positions as Vice Chairwoman of the Board of Directors cum General Director. Ms. Dao wholeheartedly works branding Imexpharm. She has had great success in developing a small pharmaceutical production enterprise in Dong Thap province to become the Imexpharm of today.

Duties

• Head of the Strategic Subcommittee of the Board of Directors;
• Monitoring development objectives and strategies of the Company and targets of the Sales Division;
• Directly managing and supervising operations of Binh Duong high tech plant (IMP4);
• Supervising production and business activities and participating in the governance of affiliate companies
• Perform other rights and duties in accordance with the law, the Company’s Charter and the Decision of the Board of Directors.

Positions in other organizations

• Member of the Board of Directors of Agimexpharm Pharmaceutical Joint Stock Company (currently listed on the Upcom), an affiliate of Imexpharm.
• Vice Chairwoman of Vietnam Pharmaceutical Companies Association (VNPCA).

Holding the core leading role through the years, bringing Imexpharm from a small factory in the unnoticeable province of Dong Thap to an enterprise within Top 5 leading Pharmaceutical organisations in Vietnam, each event, each milestone all bears the efforts of The People’s Doctor, Pharmacist Tran Thi Dao. From the arduous trip to the wholesale market of District 10 (HCMC) in the 1980s to find the right path for the Company, to the journey to European lands to find cooperation partners for production franchising, and also the equitization in 2001, making Imexpharm into the first enterprise within Vietnam General Pharmaceutical Corporation to successfully switch its model. All of these are the footsteps of a pioneer, highly difficult, but also a display of a leader’s strength.

“As a leader, I always have to be decisive, because I understand that opportunities are always present but time waits for no man”, this line still has its value to this day and is proven by several actual results. One can say the current prosperity and stable development of Imexpharm – the legacy that the “golden generation” legates for the inheriting generation – have the vastly significant contribution of The People’s Doctor. Closing the 2018 – 2022 term with many noticeable achievements considered to be the base for a new journey, Imexpharm will continue to witness the upcoming changes and breakthroughs, and will still firmly
believe in her brilliant leadership.

Employment History

• 1984 – July 2001: Director of Dong Thap Pharmaceutical Company – Pharmaceutical TW7
• August 2001 – April 2004: Chairwoman of the BOD, General Director of Imexpharm
• From May 2013: Vice Chairwoman of The BOD, General Director of Imexpharm

• Year of birth: 1972
• Hometown: South Korea
• Nationality: South Korea
• Qualification: Pharmacist, MBA

Employment History

• 2005-2009: Case Team Leader at Monitor Group
• 2009-2015: Sr. Principal, Head of Strategy & product portfolio, APAC tại IMS Consulting group, APAC & Korea
• 2015-2016: General Director at IMS Health Thailand
• 2016: VP/Portfolio II at SK Holdings
• 2017: Strategic Consultant at SUPEX Council
• 2017 to present: General Director at IQVIA, Korea

• Year of birth: 1975
• Hometown: Hung Yen
• Nationality: Vietnamese
• Qualification: Master of International Accounting - Swinburne University of Technology, Australia

Duties:

• Head of the Internal Audit and Risk Management Subcommittee of the Board of Directors (since May 24th, 2022)
• Update the production and business situation of Vietnam’s pharmaceutical industry;
• Advise on the financial activities of the Company;
• Consulting on corporate governance, and external relations with industry partners and investors.
• Perform other rights and duties in accordance with the law, the Company’s Charter, and the Decision of the Board of Directors.

Positions in other organizations:

• Chairwoman of the Board of Directors of Central Pharmaceutical Joint Stock Company CPC1;
• Member of the Board of Directors of OPC Pharma;
• Member of the Board of Directors at Sanofi Vietnam Joint Stock Company;
• Member of the Board of Directors at Sanofi Synthelabo Vietnam Pharmaceutical Joint Stock Company;

Employment History

• 1999 – 2001: Accounts receivable and tax Account at Daewoo Hanel Company Limited
• 2001 – 2002: General Accountant cum Assistant to Finance Director at Canon Vietnam Company
• 2002 – 2008: Chief Accountant of Language Link Vietnam Company
• 2008 – 2013: Chief Accountant at Kinderworld Vietnam International School Joint Stock Company
• 2013 – 2016: Finance Director at Pegasus Investment and Consultancy Joint Stock Company
• 12/2016 – Present: Member of the Board of Directors at Vietnam Pharmaceutical Corporation- Joint Stock Company
• 02/2017 – present: Member of the Board of Directors, Deputy General Director at Vietnam Pharmaceutical Corporation- Joint Stock Company

• Year of birth: 1979
• Hometown: Ha Noi
• Nationality: Vietnamese
• Qualification: Master of Banking and Finance at Monash University

Mr. Truong Minh Hung was elected as a member of the Board of Directors of Imexpharm for the first time on 30 May 2020.

Duties

• Member of the Strategy Subcommittee of the Board of Directors;
• Supporting the expansion of raw materials sources and developing new products;
• Helping to develop export markets for Imexpharm products;
• External development and provide governance advisory for the Company;
• Support for fund raising and financial investment;
• Perform other rights and duties in accordance with the law, the Company’s Charter and the Decision of the Board of Directors. 

Employment History

• 2001-2005: Auditors of VACO and Deloitte Vietnam
• 2008-2011: Senior Officer, Head of Investment Department at Infrastructure Investment Fund and VinaCapital
• 2011-2018: Investment Department – Manager, Investment Department – Senior Manager of Vietnam-Oman Investment Joint Stock Company
• 2018-2019: Deputy General Director, Investment Director of PVI Fund Management Joint Stock Company
• 2019 to present: Senior Investment Director at SK Vietnam

• Year of birth: 1973
• Hometown: Ha Noi
• Nationality: Vietnamese
• Qualification: Master of International Finance (Oxford Brookes)

Employment History

• 11/1994 - 06/2014: Audit Director, Leadership of Advisory Services Division, Leadership of the Government and Public Sector Clients Division, Ernst & Young (EY) Vietnam Limited.
• 07/2014 - 09/2016: International Consultant – World Bank, supporting the Ministry of Finance in building the Internal audit framework in Vietnam.
• 10/2016 - 11/2020: Deputy General Director – PwC Vietnam Limited.
• 12/2020 to present: Chairman of the BOD – of CGS Vietnam Governance Consultancy Joint Stock Company; Board Member – Gentis Testing Service Joint Stock Company.
• 09/2022 to present: Vice President, Executive Committee Member of Vietnam Independent Directors Association; President of Institute of Internal Auditors Vietnam – IIA Vietnam Chapter.

• Year of birth: 1979
• Hometown: Dong Thap Province
• Nationality: Vietnamese
• Qualification: Master of Business Administration (MBA)

“Using principles, norms, and ethics to build and strengthen values for Imexpharm through human orientation.”

Monitoring the implementation of the strategic objectives of the Board; In charge of supervising the disclosure of the company; Monitoring the implementation of strategic management of the company under the BSC and corporate culture; Collecting and preparing the reports of the Board and Shareholders General Assembly, on the assigned areas upon request and before meetings; Complying with rights and duties prescribed by law and the company’s charter, and the Board’s decisions.

Duties

• Head of the Human Resources, Salary, and Bonus Subcommittee (since May 24th, 2022), member of the Internal Audit and Risk Management Subcommittee and Strategic Subcommittee of the Board of Directors;
• Supervising implementation of the Company’s strategic objectives with BSC;
• Supervising the implementation of the Company’s strategic human resource development: the Imexpharm Corporate Culture, working conditions, salary and benefits, training for career development;
• Supervising the implementation and effective control of marketing;
• Managing business of health protection food;
• Perform other rights and duties in accordance with the law, the Company’s Charter and the Decision of the Board of Directors. 

Employment History

• 2004 – 2014: Secretary of the BOD, Secretary of the General Director
• 2014 – March 2015: Head of the Board of Strategy and Development, General Director Personal Assistant
• April 2015 to present: Member of the BOD, Deputy General Director

• Year of birth: 1980
• Hometown: Dong Thap
• Nationality: Vietnamese
• Qualification: Doctor of Pharmacy in France

Following investments in a series of High-tech plants under EU-GMP standard, demands for intellectual and high-ranking personnel in the pharmaceutical industry have become expedient.

Attracting human resources was a significant success of the Company in the past year, with the highlight that Mr. Le Van Nha Phuong – Doctor of Pharmacy in France officially joined Imexpharm from early 2017 at the position of Deputy General Director in charge of the Hightech Betalactam Plant in Binh Duong and R&D.

Duties

• Member of the Internal Audit and Risk Management Subcommittee; Member of Strategic Subcommittee;
• Supervising and reporting the implementation of strategic objectives of Production Division, the implementation of GMP and Safet - Quality - Environment - Control Expenses in factories;
• Managing the Betalactam High- technology factory in Binh Duong (IMP3) and the Dietary Supplement Factory;
• Supervising the implementation of the R&D Strategies of the Company;
• Perform other rights and duties in accordance with the law, the Company’s Charter and the Decision of the Board of Directors. 

Employment History

• 10/2004 – 4/2005: R&D employee at Domesco Medical Import Export Joint Stock Company.
• 4/2005 – 8/2006: Deputy Director of R&D Department at Domesco.
• 8/2006 – 8/2008: Director of Department of Export – International Supplies and Cooperation at Domesco.
• 8/2010 – 10/2011: Director of R&D Department at Domesco.
• 10/2011 – 3/2014: Deputy General Director of Domesco.
• 4/2014 – 12/2016: Director of the plant of AMPHARCO.
• 01/2017: Deputy General Director of Imexpharm Corporation, in charge of the High-tech Betalactam Plant in Binh Duong and R&D Division across the Company.
• 04/2018 - 2020: Member of Board of Directors, Deputy General Director of Imexpharm Corporation.
• 2020 - present: Deputy General Director of Imexpharm Corporation.

• Year of birth: 1973
• Hometown: Dong Thap Province
• Nationality: Vietnamese
• Qualification: Pharmacist of First Specialty

Monitoring strategic operation objectives of the Board; Monitoring implementation production sector and supervising the quality control system, labor safety and fire prevention; Collecting and preparing the reports of the Board and General Assembly of Shareholders, on the assigned areas upon request and before meetings; Complying with rights and duties prescribed by law and the company’s charter, and the Board’s decisions.

Duties

Mr. Nhung is a PGJ (Postgraduate Education Junior) with many years of experience in leading and organizing the implementation of drug quality assurance, providing professional, technical guidance on pharmaceutical work, etc.

In addition to his expertise, he also has the ability of a good and passionate manager. Since 2012, Mr. Nhung was officially appointed as Deputy General Director of Imexpharm. He is in charge of managing important areas of Production Division 1 including the quality assurance system (QA), quality control system (QC), Vinh Loc High-Tech Antibiotic Factory (IMP2), Non-Betalactam Factory, and Penicillin Factory. Concurrently, Mr. Nhung is also a member of the Company’s Sustainable Development Committee, in charge of the environment (ISO 14001), using energy, water, and occupational safety and health, jointly leading Production Division 1 operating in the right direction and making many contributions to the development of the whole Company.

Employment History

• 1998 – 2007: Deputy Director of Quality Assurance (QA) Imexpharm
• 2007 – 2012: Director of Quality Assurance Imexpharm
• 2012 – May 2013: Deputy General Director of Imexpharm
• April 2014 to present: Member of Board of Directors, Deputy General Director of Imexpharm

• Year of birth: 1974
• Hometown: Dong Thap
• Nationality: Vietnamese
• Qualification: Master of Business Administration, Banking and Finance (Bolton University)

Employment History

• 1997 – 2002: Finance Manager at Coats Co.
• 2003 - 2006: Finance Manager at Pepsico Vietnam.
• 2007 - 2019: Planning Director at Vinamilk.
• 03/2019 – 10/2020: Vice President Operations at Betrimex Vietnam.
• 02/2021 to present: Chief Financial Officer at Nutifood Vietnam.

• Year of birth: 1975
• Hometown: TP. HCM
• Nationality: United States
• Qualification: Bachelor of Science in Engineering/ Biology in US, Doctor of Pharmacy and Executive MBA in US.

Deputy General Director, in charge of Chief Strategy Officer (CSO), executing New Projects (New Initiatives), concurrently in charge of sales and marketing for OTC & ETC-I in the Northern region, and participate in planning and developing Marketing Strategies for the Company.

Employment History

• 06/2000 – 09/2004: Hardware Network Engineer, CISCO SYSTEM, INC
• 02/2013 – 08/2013: Clinical Digital Transformation Consultant - Remote, Kaiser Permanente Hospital – USA.
• 04/2012 – 07/2016: Registered Pharmacist - CVS Caremark Corporation - USA.
• 01/2013 – 06/2016: Co-founder/Pharmaceutical Director - Multrium, LLC (USA)/ Multrium (Vietnam).
• 05/2013 – 05/2016: Private Label Manger cum Director of Retail Operation - Pharmacity JSC – Vietnam.
• 06/2016 - 11/2019: Senior Healthcare/Pharmaceutical and Pharmacy Retail Consultant - Pharma Group Consulting (Vietnam)
• 02/2018 - 11/2019: Country Manager - GMG (Global Medical Group) LTD - Singapore/ Vietnam.
• 06/2018 - present: Advisory Council Member - Pharmaceutical/ Healthcare at GLG (Gerson Lehrman Group) - Japan/ Vietnam.
• 04/2020 - 04/2021: Chief Operation Officer at Thuocsi.vn
• 12/2019 - 12/2021: Founder/Chief Executive Officer of Dayton Pharma
• 01/2022 – 06/2023: Chief Executive Officer at Nam Ha Pharmaceutical Company

• Year of birth: 1963
• Hometown: Dong Thap Province
• Nationality: Vietnamese
• Qualification: Bachelor of Finance and Accounting

Mr. Hanh has been with Imexpharm for 25 years and held the position of Chief Accountant for more than 8 years. With a high sense of responsibility and dedication in his profession, Mr. Hanh has strived to maintain a healthy and transparent financial system, contributing to improving Imexpharm’s reputation and image to credit partners domestically and internationally. Especially, the commendable efforts of Mr. Hanh and the Finance and Accounting Department when implementing regulations well to access a loan of 8 million USD from the Asian Development Bank (ADB). Mr. Hanh also manages the financial decentralization and risk management at the branches, especially the sales branches of the Company. In addition, he is also responsible for managing the operating budget, managing cash flow, and always meeting the capital source for Imexpharm’s production, business and investment activities well.

Employment History

• 1988: Officer in Finance Department – Hong Ngu City, Dong Thap Province
• 1990 – 1995: Officer in Finance and Price Department – Tan Hong Commune, Dong Thap Province.
• July 1997 – February 2005: Officer in Finance and Accounting Department – Imexpharm Corp.
• March 2005 – July 2014: Vice- Head of Finance and Accounting Department – Imexpharm Corp.
• July 2014 to present: Chief Accountant – Imexpharm Corp